Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-i...Show More
peer of
competitor of
Metrics
marketSTOCKS
msh_idCOM:LUPIN
localein
websitehttps://www.lupin.com/
ipo_date2001-09-10
primary_stock_msh_idNSE:LUPIN
source_ref36d1d650-f8a3-411f-8e20-2df55003cc65
products_or_servicesGeneric drugs, branded pharmaceuticals, biosimilars, over-the-counter products, and active pharmaceutical ingredients.